{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:46:45Z","timestamp":1782460005836,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["30672073"],"award-info":[{"award-number":["30672073"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81072004"],"award-info":[{"award-number":["81072004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81372614"],"award-info":[{"award-number":["81372614"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation Project in Shanghai","award":["13ZR1432300"],"award-info":[{"award-number":["13ZR1432300"]}]},{"name":"Shanghai Science and Technology Commission Research Project","award":["19411966300"],"award-info":[{"award-number":["19411966300"]}]},{"name":"Shanghai Science and Technology Commission Research Project","award":["19140902302"],"award-info":[{"award-number":["19140902302"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cancer-associated fibroblasts (CAFs) and vasculogenic mimicry (VM) play important roles in the occurrence and development of tumors. However, the relationship between CAFs and VM formation, especially in gallbladder cancer (GBC) has not been clarified. In this study, we investigated whether gallbladder CAFs (GCAFs) can promote VM formation and tumor growth and explored the underlying molecular mechanism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A co-culture system of human GBC cells and fibroblasts or HUVECs was established. VM formation, proliferation, invasion, migration, tube formation assays, CD\n                      <jats:sub>31<\/jats:sub>\n                      -PAS double staining, optic\/electron microscopy and tumor xenograft assay were used to detect VM formation and malignant phenotypes of 3-D co-culture matrices in vitro, as well as the VM formation and tumor growth of xenografts in vivo, respectively. Microarray analysis was used to analyze gene expression profile in GCAFs\/NFs and VM (+)\/VM (\u2212) in vitro. QRT-PCR, western blotting, IHC and CIF were used to detected NOX4 expression in GCAFs\/NFs, 3-D culture\/co-culture matrices in vitro, the xenografts in vivo and human gallbladder tissue\/stroma samples. The correlation between NOX4 expression and clinicopathological and prognostic factors of GBC patients was analyzed. And, the underlying molecular mechanism of GCAFs promoting VM formation and tumor growth in GBC was explored.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>GCAFs promote VM formation and tumor growth in GBC; and the finding was confirmed by facts that GCAFs induced proliferation, invasion, migration and tube formation of GBC cells in vitro, and promoted VM formation and tumor growth of xenografts in vivo. NOX4 is highly expressed in GBC and its stroma, which is the key gene for VM formation, and is correlated with tumor aggression and survival of GBC patients. The GBC patients with high NOX4 expression in tumor cells and stroma have a poor prognosis. The underlying molecular mechanism may be related to the upregulation of NOX4 expression through paracrine IL-6 mediated IL-6\/JAK\/STAT3 signaling pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>GCAFs promote VM formation and tumor growth in GBC via upregulating NOX4 expression through the activation of IL-6-JAK-STAT3 signal pathway. NOX4, as a VM-related gene in GBC, is overexpressed in GBC cells and GCAFs, which is related to aggression and unfavorable prognosis of GBC patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-020-01742-4","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T06:04:00Z","timestamp":1604556240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway"],"prefix":"10.1186","volume":"39","author":[{"given":"Mu-Su","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamar Hasan","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Zu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"1742_CR1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/CCO.0b013e3283620fd8","volume":"5","author":"MG McNamara","year":"2013","unstructured":"McNamara MG, Metran-Nascente C, Knox JJ. State-of-the-art in the management of locally advanced and metastatic gallbladder cancer. Curr Opin Oncol. 2013;5:425\u201331.","journal-title":"Curr Opin Oncol"},{"key":"1742_CR2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40471-016-0083-7","volume":"3","author":"MC Stern","year":"2016","unstructured":"Stern MC, Fejerman L, Das R, Setiawan VW, Cruz-Correa MR, Perez-Stable EJ, et al. Variability in cancer risk and outcomes within US latinos by national origin and genetic ancestry. Curr Epidemiol Rep. 2016;3:181\u201390.","journal-title":"Curr Epidemiol Rep"},{"key":"1742_CR3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","volume":"47","author":"H Nakamura","year":"2015","unstructured":"Nakamura H, Arai Y, Totoki Y, Shirota T, Elzawahry A, Kato M, et al. Genomic spectra of biliary tract cancer. Nat Genet. 2015;47:1003\u201310.","journal-title":"Nat Genet"},{"key":"1742_CR4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/35077241","volume":"411","author":"LA Liotta","year":"2001","unstructured":"Liotta LA, Kohn EC. The microenvironment of the tumor-host interface. Nature. 2001;411:375\u20139.","journal-title":"Nature."},{"key":"1742_CR5","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423\u201337.","journal-title":"Nat Med"},{"key":"1742_CR6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41575-019-0115-0","volume":"16","author":"H Kobayashi","year":"2019","unstructured":"Kobayashi H, Atsushi E, Woods SL, Burt AD, Takahashi M, Worthley D. Cancer-associated fibroblasts in gastrointestinal cancer. Nat Rev Gastroenterol Hepatol. 2019;16:282\u201395.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1742_CR7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1475-2867-14-41","volume":"14","author":"G Kharaishvili","year":"2014","unstructured":"Kharaishvili G, Simkova D, Bouchalova K, Gachechiladze M, Narsia N, Bouchal J. The role of cancer associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance. Cancer Cell Int. 2014;14:41.","journal-title":"Cancer Cell Int"},{"key":"1742_CR8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1158\/0008-5472.CAN-14-1317","volume":"75","author":"Y Yamamura","year":"2015","unstructured":"Yamamura Y, Asai N, Enomoto A, Kato T, Mii S, Kondo Y, et al. Akt-Girdin signaling in cancer-associated fibroblasts contributes to tumor progression. Cancer Res. 2015;75:813\u201323.","journal-title":"Cancer Res"},{"key":"1742_CR9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13046-019-1277-x","volume":"38","author":"Y Wang","year":"2019","unstructured":"Wang Y, Jing Y, Ding L, Zhang X, Song Y, Chen S, et al. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway. J Exp Clin Cancer Res. 2019;38:274.","journal-title":"J Exp Clin Cancer Res"},{"key":"1742_CR10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2018.12.009","volume":"444","author":"S Takeda","year":"2019","unstructured":"Takeda S, Shigeyasu K, Okugawa Y, Yoshida K, Mori Y, Yano S, et al. Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer. Cancer Lett. 2019;444:127\u201335.","journal-title":"Cancer Lett"},{"key":"1742_CR11","first-page":"3055","volume":"17","author":"FT Wang","year":"2019","unstructured":"Wang FT, Wei S, Zhang JT, Fan YZ. Cancer-associated fibroblast regulation of tumor neo-angiogenesis as a therapeutic target in cancer. Oncol Lett. 2019;17:3055\u201365.","journal-title":"Oncol Lett"},{"key":"1742_CR12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1042\/CS20200039","volume":"134","author":"J Fan","year":"2020","unstructured":"Fan J, Xu G, Chang Z, Zhu L, Yao J. miR-210 transferred by lung cancer cell-derived exosomes may act as proangiogenic factor in cancer-associated fibroblasts by modulating JAK2\/STAT3 pathway. Clin Sci. 2020;134:807\u201325.","journal-title":"Clin Sci"},{"key":"1742_CR13","first-page":"1475","volume":"42","author":"FT Wang","year":"2019","unstructured":"Wang FT, Mohamed MH, Ansari KH, Xu GL, Li XP, Fan YZ. Upregulated NOX1 expression in gallbladder cancer associated fibroblasts predicts a poor prognosis. Oncol Rep. 2019;42:1475\u201386.","journal-title":"Oncol Rep"},{"key":"1742_CR14","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1002\/cam4.1704","volume":"7","author":"M Sha","year":"2018","unstructured":"Sha M, Jeong S, Qiu BJ, Tong Y, Xia L, Xu N, et al. Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma. Cancer Med. 2018;7:4665\u201377.","journal-title":"Cancer Med"},{"key":"1742_CR15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/odi.13140","volume":"26","author":"D Graizel","year":"2020","unstructured":"Graizel D, Zlotogorski-Hurvitz A, Tsesis I, Rosen E, Kedem R, Vered M. Oral cancer-associated fibroblasts predict poor survival: systematic review and meta-analysis. Oral Dis. 2020;26:733\u201344.","journal-title":"Oral Dis"},{"key":"1742_CR16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.semcancer.2019.06.015","volume":"59","author":"WC Cho","year":"2019","unstructured":"Cho WC, Jour G, Aung PP. Role of angiogenesis in melanoma progression: update on key angiogenic mechanisms and other associated components. Semin Cancer Biol. 2019;59:175\u201386.","journal-title":"Semin Cancer Biol"},{"key":"1742_CR17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pharmthera.2018.07.006","volume":"193","author":"Y Hisano","year":"2019","unstructured":"Hisano Y, Hla T. Bioactive lysolipids in cancer and angiogenesis. Pharmacol Ther. 2019;193:91\u20138.","journal-title":"Pharmacol Ther"},{"key":"1742_CR18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","volume":"155","author":"AJ Maniotis","year":"1999","unstructured":"Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe\u2019er J, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999;155:739\u201352.","journal-title":"Am J Pathol"},{"key":"1742_CR19","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1111\/jcmm.15217","volume":"24","author":"M Wang","year":"2020","unstructured":"Wang M, Yang C, Liu X, Zheng J, Xue Y, Ruan X, et al. An upstream open reading frame regulates vasculogenic mimicry of glioma via ZNRD1-AS1\/miR-499a-5p\/ELF1\/EMI1 pathway. J Cell Mol Med. 2020;24:6120\u201336.","journal-title":"J Cell Mol Med"},{"key":"1742_CR20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1756-9966-30-46","volume":"30","author":"W Sun","year":"2011","unstructured":"Sun W, Fan YZ, Zhang WZ, Ge CY. A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro. J Exp Clin Cancer Res. 2011;30:46\u201358.","journal-title":"J Exp Clin Cancer Res"},{"key":"1742_CR21","doi-asserted-by":"publisher","unstructured":"Qiao K, Liu Y, Xu Z, Zhang H, Zhang H, Zhang C, et al. RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via hippo pathway. Angiogenesis. 2020. https:\/\/doi.org\/10.1007\/s10456-020-09744-8.","DOI":"10.1007\/s10456-020-09744-8"},{"key":"1742_CR22","doi-asserted-by":"publisher","unstructured":"Zhao J, Wu J, Qin Y, Zhang W, Huang G, Qin L, et al. LncRNA PVT1 induces aggressive vasculogenic mimicry formation through activating the STAT3\/slug axis and epithelial-to-mesenchymal transition in gastric cancer. Cell Oncol (Dordr). 2020. https:\/\/doi.org\/10.1007\/s13402-020-00532-6.","DOI":"10.1007\/s13402-020-00532-6"},{"key":"1742_CR23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/1471-2407-14-193","volume":"14","author":"JT Zhang","year":"2014","unstructured":"Zhang JT, Sun W, Zhang WZ, Ge CY, Liu ZY, Zhao ZM, et al. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K\/MMPs\/Ln-5\u03b32 signaling pathway. BMC Cancer. 2014;14:193.","journal-title":"BMC Cancer"},{"key":"1742_CR24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.actbio.2019.06.039","volume":"94","author":"Y Wang","year":"2019","unstructured":"Wang Y, Tong L, Wang J, Luo J, Tang J, Zhong L, et al. cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer. Acta Biomater. 2019;94:495\u2013504.","journal-title":"Acta Biomater"},{"key":"1742_CR25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41392-020-0167-1","volume":"5","author":"B Zhao","year":"2020","unstructured":"Zhao B, Wu M, Hu Z, Ma Y, Qi W, Zhang Y, et al. Thrombin is a therapeutic target for non-small-cell lung cancer to inhibit vasculogenic mimicry formation. Signal Transduct Target Ther. 2020;5:117.","journal-title":"Signal Transduct Target Ther"},{"key":"1742_CR26","first-page":"145","volume":"87","author":"YZ Fan","year":"2007","unstructured":"Fan YZ, Sun W, Zhang WZ, Ge CY. Vasculogenic mimicry in human primary gallbladder carcinoma and clinical significance thereof. Nalt Med J China. 2007;87:145\u20139.","journal-title":"Nalt Med J China"},{"key":"1742_CR27","first-page":"1990","volume":"27","author":"W Sun","year":"2012","unstructured":"Sun W, Shen ZY, Zhang H, Fan YZ, Zhang WZ, Zhang JT, et al. Overexpression of HIF-1\u03b1 in primary gallbladder carcinoma and its relation to vasculogenic mimicry and unfavorable prognosis. Oncol Rep. 2012;27:1990\u20132002.","journal-title":"Oncol Rep"},{"key":"1742_CR28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4240\/wjgs.v2.i4.117","volume":"2","author":"YZ Fan","year":"2010","unstructured":"Fan YZ, Sun W. Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy. World J Gastroint Surg. 2010;2:117\u201327.","journal-title":"World J Gastroint Surg"},{"key":"1742_CR29","doi-asserted-by":"crossref","first-page":"e96882","DOI":"10.1371\/journal.pone.0096882","volume":"9","author":"H Wang","year":"2014","unstructured":"Wang H, Sun W, Zhang WZ, Ge CY, Zhang JT, Liu ZY, et al. Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2\/focal adhesion kinase\/Paxillin signaling pathway. PLoS One. 2014;9:e96882.","journal-title":"PLoS One"},{"key":"1742_CR30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2016.09.012","volume":"383","author":"J Yang","year":"2016","unstructured":"Yang J, Lu Y, Lin YY, Zheng ZY, Fang JH, He S, et al. Vascular mimicry formation is promoted by paracrine TGF-\u03b2 and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma. Cancer Lett. 2016;383:18\u201327.","journal-title":"Cancer Lett"},{"key":"1742_CR31","first-page":"1185","volume":"40","author":"XS Ding","year":"2018","unstructured":"Ding XS, Xi WQ, Ji J, Cai Q, Jiang JL, Shi M, et al. HGF derived from cancer-associated fibroblasts promotes vascularization in gastric cancer via PI3K\/AKT and ERK1\/2 signaling. Oncol Rep. 2018;40:1185\u201395.","journal-title":"Oncol Rep"},{"key":"1742_CR32","first-page":"3031","volume":"18","author":"HS Kim","year":"2019","unstructured":"Kim HS, Won YJ, Shim JH, Kim HJ, Kim BS, Hong HN. Role of EphA2-PI3K signaling in vasculogenic mimicry induced by cancer-associated fibroblasts in gastric cancer cells. Oncol Lett. 2019;18:3031\u20138.","journal-title":"Oncol Lett"},{"key":"1742_CR33","first-page":"6548","volume":"6","author":"KH Ansari","year":"2019","unstructured":"Ansari KH, Fan YZ. NADPH oxidase 4 (NOX4) and cancer. Eur J Pharm Med Res (EJPMR). 2019;6:6548.","journal-title":"Eur J Pharm Med Res (EJPMR)"},{"key":"1742_CR34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","volume":"8","author":"D Trachootham","year":"2009","unstructured":"Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach. Nat Rev Drug Discov. 2009;8:579\u201391.","journal-title":"Nat Rev Drug Discov"},{"key":"1742_CR35","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1089\/ars.2013.5603","volume":"20","author":"JL Meitzler","year":"2014","unstructured":"Meitzler JL, Antony S, Wu Y, Juhasz A, Liu H, Jiang G, et al. NADPH oxidases: a perspective on reactive oxygen species production in tumor biology. Antioxid Redox Signal. 2014;20:2873\u201389.","journal-title":"Antioxid Redox Signal"},{"key":"1742_CR36","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1042\/CS20140542","volume":"128","author":"K Roy","year":"2015","unstructured":"Roy K, Wu Y, Meitzler JL, Juhasz A, Liu H, Jiang G, et al. NADPH oxidases and cancer. Clin Sci. 2015;128:863\u201375.","journal-title":"Clin Sci"},{"key":"1742_CR37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.canlet.2013.08.014","volume":"345","author":"Y Wu","year":"2014","unstructured":"Wu Y, Antony S, Meitzler JL, Doroshow JH. Molecular mechanisms underlying chronic inflammation\u00adassociated cancers. Cancer Lett. 2014;345:164\u201373.","journal-title":"Cancer Lett"},{"key":"1742_CR38","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/leu.2015.234","volume":"30","author":"AK Jayavelu","year":"2016","unstructured":"Jayavelu AK, M\u00fcller JP, Bauer R, B\u00f6hmer SA, L\u00e4ssig J, Cerny-Reiterer S, et al. NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cells. Leukemia. 2016;30:473.","journal-title":"Leukemia."},{"key":"1742_CR39","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.7150\/thno.44744","volume":"10","author":"CJ Shen","year":"2020","unstructured":"Shen CJ, Chang KY, Lin BW, Lin WT, Su CM, Tsai JP, et al. Oleic acid-induced NOX4 is dependent on ANGPTL4 expression to promote human colorectal cancer metastasis. Theranostics. 2020;10:7083\u201399.","journal-title":"Theranostics"},{"key":"1742_CR40","doi-asserted-by":"crossref","first-page":"101116","DOI":"10.1016\/j.redox.2019.101116","volume":"22","author":"J Zhang","year":"2019","unstructured":"Zhang J, Li H, Wu Q, Chen Y, Deng Y, Yang Z, et al. Tumoral NOX4 recruits M2 tumor-associated macrophages via ROS\/PI3K signaling-dependent various cytokine production to promote NSCLC growth. Redox Biol. 2019;22:101116.","journal-title":"Redox Biol"},{"key":"1742_CR41","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.2147\/OTT.S161287","volume":"11","author":"X You","year":"2018","unstructured":"You X, Ma M, Hou G, Hu Y, Shi X. Gene expression and prognosis of NOX family members in gastric cancer. OncoTargets Ther. 2018;11:3065.","journal-title":"OncoTargets Ther"},{"key":"1742_CR42","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/apha.12625","volume":"216","author":"V Helfinger","year":"2016","unstructured":"Helfinger V, Henke N, Harenkamp S, Walter M, Epah J, Penski C, et al. The NADPH oxidase Nox4 mediates tumour angiogenesis. Acta Physiol (Oxford). 2016;216:435\u201346.","journal-title":"Acta Physiol (Oxford)"},{"key":"1742_CR43","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12935-017-0388-8","volume":"17","author":"ZY Liu","year":"2017","unstructured":"Liu ZY, Xu GL, Tao HH, Yang YQ, Fan YZ. Establishment and characterization of a novel highly aggressive gallbladder cancer cell line, TJ-GBC2. Cancer Cell Int. 2017;17:20.","journal-title":"Cancer Cell Int"},{"key":"1742_CR44","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jhep.2008.07.021","volume":"49","author":"I Carmona-Cuenca","year":"2008","unstructured":"Carmona-Cuenca I, Roncero C, Sancho P, Caja L, Fausto N, Fern\u00e1ndez M, et al. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity. J Hepatol. 2008;49:965\u201376.","journal-title":"J Hepatol"},{"key":"1742_CR45","doi-asserted-by":"crossref","first-page":"14437","DOI":"10.1038\/ncomms14437","volume":"8","author":"HQ Ju","year":"2017","unstructured":"Ju HQ, Ying HQ, Tian T, Ling JH, Fu J, Lu Y, et al. Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma. Nat Commun. 2017;8:14437.","journal-title":"Nat Commun"},{"key":"1742_CR46","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1158\/0008-5472.CAN-13-2979","volume":"74","author":"JL Gregg","year":"2014","unstructured":"Gregg JL, Turner RM, Chang GM, Joshi D, Zhan Y, Chen L, et al. NADPH oxidase NOX4 supports renal tumorigenesis by promoting the expression and nuclear accumulation of HIF2\u03b1. Cancer Res. 2014;74:3501\u201311.","journal-title":"Cancer Res"},{"key":"1742_CR47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cellsig.2018.02.007","volume":"46","author":"CT Tang","year":"2018","unstructured":"Tang CT, Lin XL, Wu S, Liang Q, Yang L, Gao YJ, et al. NOX4-driven ROS formation regulates proliferation and apoptosis of gastric cancer cells through the GLI1 pathway. Cell Signal. 2018;46:52\u201363.","journal-title":"Cell Signal"},{"key":"1742_CR48","doi-asserted-by":"crossref","first-page":"33586","DOI":"10.18632\/oncotarget.16829","volume":"8","author":"XL Lin","year":"2017","unstructured":"Lin XL, Yang L, Fu SW, Lin WF, Gao YJ, Chen HY, et al. Overexpression of NOX4 predicts poor prognosis and promotes tumor progression in human colorectal cancer. Oncotarget. 2017;8:33586\u2013600.","journal-title":"Oncotarget."},{"key":"1742_CR49","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nm.3848","volume":"21","author":"CS Ilkow","year":"2015","unstructured":"Ilkow CS, Marguerie M, Batenchuk C, Mayer J, Neriah DB, Cousineau S, et al. Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity. Nat Med. 2015;21:530\u20136.","journal-title":"Nat Med"},{"key":"1742_CR50","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21:309\u201322.","journal-title":"Cancer Cell"},{"key":"1742_CR51","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16:448\u201357.","journal-title":"Nat Immunol"},{"key":"1742_CR52","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.it.2014.12.008","volume":"36","author":"J Mauer","year":"2015","unstructured":"Mauer J, Denson JL, Br\u00fcning JC. Versatile functions for IL-6 in metabolism and cancer. Trends Immunol. 2015;36:92\u2013101.","journal-title":"Trends Immunol"},{"key":"1742_CR53","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/1078-0432.CCR-14-2291","volume":"21","author":"JF Rossi","year":"2015","unstructured":"Rossi JF, Lu ZY, Jourdan M, Klein B. Interleukin-6 as a therapeutic target. Clin Cancer Res. 2015;21:1248\u201357.","journal-title":"Clin Cancer Res"},{"key":"1742_CR54","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cell.2013.09.031","volume":"155","author":"GB He","year":"2013","unstructured":"He GB, Dhar D, Nakagawa H, Font-Burgada J, Ogata H, Jiang YH, et al. Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell. 2013;155:384\u201396.","journal-title":"Cell."},{"key":"1742_CR55","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/path.2935","volume":"225","author":"S Shinriki","year":"2011","unstructured":"Shinriki S, Jono H, Ueda M, Ota K, Ota T, Sueyoshi T, et al. Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma. J Pathol. 2011;225:142\u201350.","journal-title":"J Pathol"},{"key":"1742_CR56","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O'Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15:234\u201348.","journal-title":"Nat Rev Clin Oncol"},{"key":"1742_CR57","doi-asserted-by":"crossref","first-page":"15433","DOI":"10.1038\/ncomms15433","volume":"8","author":"M Zhou","year":"2017","unstructured":"Zhou M, Yang H, Learned RM, Tian H, Ling L. Non-cell-autonomous activation of IL-6\/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis. Nat Commun. 2017;8:15433.","journal-title":"Nat Commun"},{"key":"1742_CR58","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1038\/s41467-018-05852-8","volume":"9","author":"RX Chang","year":"2018","unstructured":"Chang RX, Song LL, Xu Y, Wu YJ, Dai C, Wang XY, et al. Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2\/STAT3 axis. Nat Commun. 2018;9:3486.","journal-title":"Nat Commun"},{"key":"1742_CR59","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1172\/JCI31871","volume":"117","author":"SP Gao","year":"2007","unstructured":"Gao SP, Mark KG, Leslie K, Pao W, Motoi N, Gerald WL, et al. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J Clin Invest. 2007;117:3846\u201356.","journal-title":"J Clin Invest"}],"updated-by":[{"DOI":"10.1186\/s13046-021-02014-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T00:00:00Z","timestamp":1626480000000}}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-020-01742-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-020-01742-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-020-01742-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T02:06:42Z","timestamp":1626574002000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-020-01742-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1742"],"URL":"https:\/\/doi.org\/10.1186\/s13046-020-01742-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-64358\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-64358\/v2","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]},"assertion":[{"value":"22 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13046-021-02014-5","URL":"https:\/\/doi.org\/10.1186\/s13046-021-02014-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee and the Institutional Review Board at the Tongji Hospital. All patients provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"234"}}